Bright Future Pharmaceutical Group
About Bright Future Pharmaceutical Group
Categories
-
HK
-
2018On CPHI since
-
25 - 49Employees
Company types
Products from Bright Future Pharmaceutical Group (3)
-
Product Amoxicillin and Clavulanate Potassium for Oral Suspension (7:1)
Infections caused by susceptible strains of the designated organisms in the conditions listed below:1) Lower respiratory Tract infections
2) Otitis Media
3) Sinusitis
4) Urinary Tract Infections -
Product Amoxicillin Capsules 250mg
Infections caused by sensitive bacteria, such as:1) Respiratory tract infection (pneumonia, acute and chronic bronchitis, tonsillitis, otitis media, etc.);
2) Reproductive urinary tract infection (gonorrhea, urethritis, cystitis, pyelonephritis, etc.);
3) Skin and soft tissue infection;
4) t... -
Product Amoxicillin capsules 500mg
Infections caused by sensitive bacteria, such as:1) Respiratory tract infection (pneumonia, acute and chronic bronchitis, tonsillitis, otitis media, etc.);
2) Reproductive urinary tract infection (gonorrhea, urethritis, cystitis, pyelonephritis, etc.);
3) Skin and soft tissue infection;
4) typhoid...
Bright Future Pharmaceutical Group Resources (1)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance